# Marrone Bio Innovations

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/marrone-bio-innovations

- Industry: Agribusiness
- Headquarters: Davis, US
- Website: www.marroneorganicinnovations.com
- Total disclosed funding: $39M
- Latest round: Series C (Jun 1, 2011)
- Investors on record: 9

## About

Marrone Bio Innovations, Inc. is a biotechnology company specializing in developing and commercializing innovative biological products for agriculture, focusing on sustainable and environmentally friendly solutions.Marrone Bio Innovations, Inc. was founded in 2006 in Davis, US. The company develops biological products that enhance agricultural productivity while being environmentally conscious. Marco Anastasia, its founder, has a history in biotechnology and has guided the firm through its strategic developments. The company successfully raised USD 10.00 mn in VENTURE DEBT funding, led by the U.S. Department of Agriculture, contributing to a total capital raised of USD 57.00 mn since its IPO in August 2013, which valued the company at USD 178 million.Marrone Bio Innovations offers a range of biological solutions designed to improve crop health and yield. Their primary products include biopesticides and biofertilizers tailored for various agricultural applications, aimed at reducing reliance on synthetic chemicals. The company's offerings cater to a diverse customer base, including farmers and agricultural businesses across North America and Europe, providing environmentally sustainable alternatives that promote soil health and pest management.In the most recent fiscal year 2021, Marrone Bio Innovations reported revenue of USD 44.31 mn, with an EBITDA of USD -10.84 mn, reflecting the investments made into developing their product offerings and market expansion.Marrone Bio Innovations aims to innovate further with new product launches scheduled over the next year, targeting additional markets in Latin America and Asia by 2024. The recent funding secured will be allocated towards research and development for these new products and expanding their market presence. The firm anticipates that the development of biological solutions will align with increasing global demand for sustainable agriculture practices.

## Funding rounds

- Series C, Jun 1, 2011, $18M — Mitsui Global Investment, Calvert Social Venture, Saffron Hill Ventures, Clean Pacific Ventures, One Earth Capital, Stuart Mill Venture Partners, The Contrarian Group, Syngenta Ventures
- Series C, Mar 17, 2010, $7.1M — Wavepoint Ventures
- Series B, Aug 6, 2008, $10M — Saffron Hill Ventures, Wavepoint Ventures, Clean Pacific Ventures, One Earth Capital, Stuart Mill Venture Partners, The Contrarian Group
- Series A, Apr 20, 2007, $3.8M — Calvert Social Venture, Saffron Hill Ventures, Wavepoint Ventures, Clean Pacific Ventures, One Earth Capital

## Investors

- Calvert Social Venture (https://capitalatlas.ai/funds/calvert-social-venture) — Series A, Series C
- Saffron Hill Ventures (https://capitalatlas.ai/funds/saffron-hill-ventures) — Series A, Series B, Series C
- Wavepoint Ventures (https://capitalatlas.ai/funds/wavepoint-ventures) — Series A, Series B, Series C
- Clean Pacific Ventures (https://capitalatlas.ai/funds/clean-pacific-ventures) — Series A, Series B, Series C
- One Earth Capital (https://capitalatlas.ai/funds/one-earth-capital) — Series A, Series B, Series C
- Stuart Mill Venture Partners (https://capitalatlas.ai/funds/stuart-mill-venture-partners) — Series B, Series C
- The Contrarian Group (https://capitalatlas.ai/funds/the-contrarian-group) — Series B, Series C
- Mitsui Global Investment (https://capitalatlas.ai/funds/mitsui-global-investment) — Series C
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series C